FGF2 and neoplasm: In contrast, their monotherapy had no impact on tumor cell proliferation in FGF-2+ tumors, although anti-VEGF and imatinib monotherapy significantly inhibited tumor cell proliferation in FGF-2− tumors (Fig. 5a–c).